STAT
STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit
Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in hand showing many patients remained off of other therapies a…
Meghana Keshavan
Rights: fair use excerpt
Reporting by Meghana KeshavanSource: STAT NewsPhoto: Courtesy Tslil Ast Mootha LaboratoryUpdated October 6, 2026
---
Meghana Keshavan · STAT News · Photo: Courtesy Tslil Ast Mootha Laboratory
Source & Credit
Reporting and photography credited as noted above. Originally published by STAT News.
Members only
Checking your membership…